tykhr
sign in
free sign up
Freeline Therapeutics Holdings Plc
Biotechnology
Healthcare
FRLN
4.34 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
6.32
52 week high
6.75
high
6.40
52 week low
1.40
low
6.32
growth
107.47 %
previous Close
6.37
P/E ratio
market cap
15.82 M
div yield
0
usd
Sep 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
2594.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top